Cargando…
Validation and Invalidation of SARS-CoV-2 Papain-like Protease Inhibitors
[Image: see text] SARS-CoV-2 encodes two viral cysteine proteases, the main protease (M(pro)) and the papain-like protease (PL(pro)), both of which are validated antiviral drug targets. PL(pro) is involved in the cleavage of viral polyproteins as well as immune modulation by removing ubiquitin and i...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806001/ https://www.ncbi.nlm.nih.gov/pubmed/35178512 http://dx.doi.org/10.1021/acsptsci.1c00240 |